Clinical Trial Update: MINDD 3: Prediabetes and Delay Discounting [NA]

View source ↗

Summary

A completed clinical trial (MINDD 3) investigating prediabetes and delay discounting has posted results in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Snippet

Sponsor: Leonard Epstein | Conditions: PreDiabetes | NA | Status: COMPLETED | Results posted: 2022-08-04